Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
19-22 October, 2025
Not Confirmed
Not Confirmed
20-22 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
19-22 October, 2025
Industry Trade Show
Not Confirmed
20-22 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-are-building-capabilities-to-stay-ahead-of-the-curve-and-align-with-future-needs-of-global-healthcare
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india
09 Oct 2025
// PHARMIWEB
https://www.pharmiweb.com/press-release/2025-10-09/vir-biotechnology-announces-first-patient-dosed-in-part-3-of-phase-1-trial-of-psma-targeting-pro-xte
25 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250825415674/en/Vir-Biotechnology-to-Participate-in-the-Morgan-Stanley-23rd-Annual-Global-Healthcare-Conference
06 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250806509549/en/Vir-Biotechnology-Successfully-Initiates-all-Trials-in-ECLIPSE-Registrational-Program-for-Chronic-Hepatitis-Delta
06 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250806662203/en/Vir-Biotechnology-Provides-Corporate-Update-and-Reports-Second-Quarter-2025-Financial-Results
31 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250731294819/en/Vir-Biotechnology-Initiates-Second-Pivotal-Trial-in-Its-Global-ECLIPSE-Registrational-Program-for-Chronic-Hepatitis-Delta
22 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250722070067/en/Vir-Biotechnology-to-Provide-Corporate-Update-and-Report-Second-Quarter-2025-Financial-Results-on-August-6-2025
ABOUT THIS PAGE